Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: David L. Johnson who wrote (3787)	5/20/1999 10:29:00 AM
From: Grant MacMillan	Read Replies (2) \| Respond to of 8117

Thanks for the input and while I agree this makes sense, there were obviously not enough people in the military evaluation to value this enough to rank the Fast1 as the clear winner. So, while in our minds, the Fast 1 is #1, this has not been the definitive conclusion of independent observers. I would like to follow up on your suggestion with respect to speaking to paramedics, as I see the civilian market as representing the largest market for Fast1. Are there any hospitals in the Toronto market using the product currently, either through trial or otherwise? GM

To: David L. Johnson who wrote (3787)	5/20/1999 10:57:00 AM
From: LOR	Respond to of 8117

It was nice to see that PYNG finally "bit the bullet" and commented on the results of the WR tests. I guess it is only natural that "facts" got mixed in with "opinions" in Michael's commentary and I happen to agree that the test results leave no doubt that the FAST-1 is "the best" product for use in the vast majority of "NON- combat" situations. That said, it would be nice to know: a) what were "the numbers" of medics which preferred the FAST-1 versus each of the other devices. After all, if 9 medics preferred products "A" and "B" and 8 medics preferred product "C" it would indicate that there was not much of a difference between 3 of the 4 products for a "combat" environment, b) are there any detailed technical results from PYNG's "civilian" trials that you can share with us? c) what percentage of PYNG's forecasted $ 250,000,000 world market is actually in North America ? Rest assured most of us think the FAST-1 is a terrific product but wonder why PYNG appears to be a relative unknown with much of the potential client base. LOR P.S.- I'm glad to hear that you really are NOT chained to your lab door ...